CONTACT INFORMATION
Specialties
Heart Disease, Vascular Disease, Abdominal Aortic Aneurysm
Board Certifications
Cardiovascular Disease - Subspecialty Cert: AM Board of Internal Medicine
Internal Medicine - General Cert: AM Board of Internal Medicine
Interventional Cardiology - Subspecialty Cert: AM Board of Internal Medicine
Publications
An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers. Gomes,M.; Ramacciotti,E.; Hoppensteadt,D.; Walenga,J. M.; Lewis,B.; Thethi,I.; Fareed,J. Clinical & Applied Thrombosis/Hemostasis 2011 ;17(1):66-69
Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting. Dieter,R. S.; Darki,A.; Nanjundappa,A.; Chhokar,V. S.; Khadim,G.; Morshedi-Meibodi,A.; Freihage,J. H.; Steen,L.; Lewis,B.; Leya,F. American Journal of Cardiology 2009 ;104(5):732-734
Argatroban in percutaneous coronary indications Iqbal,O.; Adiguzel,C.; Lewis,B. E.; Cunanan,J.; Fareed,J. Seminars in Thrombosis and Hemostasis 2008 ;34( ):75
Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition. Kelton,J. G.; Hursting,M. J.; Heddle,N.; Lewis,B. E. Blood Coagulation & Fibrinolysis 2008 ;19(6):471-475
Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin Ramana,R. K.; Lewis,B. E. Vascular Health & Risk Management 2008 ;4(3):493-505
Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Ramana,R. K.; Ronan,A.; Cohoon,K.; Homan,D.; Sutherland,J.; Steen,L.; Liu,J.; Loeb,H.; Lewis,B. E. Catheterization & Cardiovascular Interventions 2008 ;71(7):886-893
Femoral angiogram prior to arteriotomy closure device does not reduce vascular complications in patients undergoing cardiac catheterization. Ramana,R. K.; Singh,A.; Dieter,R. S.; Moran,J. F.; Steen,L.; Lewis,B. E.; Leya,F. Journal of interventional cardiology 2008 ;21(2):204-208
Invasive assessment of mitral regurgitation: comparison of hemodynamic parameters. Freihage,J. H.; Joyal,D.; Arab,D.; Dieter,R. S.; Loeb,H. S.; Steen,L.; Lewis,B.; Liu,J. C.; Leya,F. Catheterization & Cardiovascular Interventions 2007 ;69(2):303-312
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Lewis,B. E.; Hursting,M. J. Expert Review of Cardiovascular Therapy 2007 ;5(1):57-68
The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis. Joyal,D.; Freihage,J. H.; Cohoon,K.; Tempelhof,M.; Leya,F.; Dieter,R. S.; Steen,L.; Lewis,B.; Arab,D. Journal of Invasive Cardiology 2007 ;19(7):291-294
Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease. Joyal,D.; Leya,F.; Al Chekakie,M. O.; Arab,D.; Dieter,R. S.; Morshedi-Meibodi,A.; Lewis,B.; Steen,L.; Fareed,J.; Hoppenstead,D.; Akar,J. G. Coronary artery disease 2007 ;18(6):471-475
Troponin I levels in patients with preeclampsia. Joyal,D.; Leya,F.; Koh,M.; Besinger,R.; Ramana,R.; Kahn,S.; Jeske,W.; Lewis,B.; Steen,L.; Mestril,R.; Arab,D. American Journal of Medicine 2007 ;120(9):819.e13-819.e14
Utility of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy in patients with renal insufficiency. Reddy,P. R.; Dieter,R. S.; Das,P.; Steen,L. H.; Lewis,B. E.; Leya,F. S. Journal of cardiac failure 2007 ;13(8):668-671
Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia Lewis,B. E.; Wallis,D. E.; Hursting,M. J.; Levine,R. L.; Leya,F. Chest 2006 ;129(6):1407-1416
Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunction Ramana,R. K.; Joyal,D.; Arab,D.; Dieter,R. S.; Steen,L.; Lewis,B.; Leya,F. Journal of Invasive Cardiology 2006 ;18(11):514-518
Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era Ramana,R. K.; Arab,D.; Joyal,D.; Steen,L.; Cho,L.; Lewis,B.; Liu,J.; Loeb,H.; Leya,F. Journal of Invasive Cardiology 2005 ;17(11):603-605
Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention. Cho,L.; Lewis,B. E.; Steen,L. H.; Leya,F. S. Cardiology 2005 ;104(2):97-100
Antiplatelet therapy in anticoagulated patients requiring coronary intervention Arab,D.; Lewis,B.; Cho,L.; Steen,L.; Joyal,D.; Leya,F. Journal of Invasive Cardiology 2005 ;17(10):549-554
The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. Leya,F. S.; Arab,D.; Joyal,D.; Shioura,K. M.; Lewis,B. E.; Steen,L. H.; Cho,L. Journal of the American College of Cardiology 2005 ;45(11):1900-1902
Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use. Tobu,M.; Iqbal,O.; Ma,Q.; Schultz,C.; Jeske,W.; Hoppensteadt,D.; Lewis,B.; Fareed,D.; Fareed,J. Clinical & Applied Thrombosis/Hemostasis 2003 ;9(1):1-17
New catheter design for cannulation of the anomalous right coronary artery arising from the left sinus of valsalva. Qayyum,U.; Leya,F.; Steen,L.; Sochanski,M.; Grassman,E.; Cho,L.; Lewis,B. Catheterization & Cardiovascular Interventions 2003 ;60(3):382-388
Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia Cochran,K.; DeMartini,T. J.; Lewis,B. E.; O'Brien,J.; Steen,L. H.; Grassman,E. D.; Leya,F. Journal of Invasive Cardiology 2003 ;15(11):617-621
Education
Medical School
Rush Medical College of Rush University
Residency
Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine: General
Fellowship
Loyola University Medical Center, Cardiology
Languages
Spanish
Interests & Hobbies
Basketball
Tennis
Gardening